Geode Capital Management’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98.1K | Buy |
|
|||||
|
2025
Q1 | $75.8K | Sell |
|
|||||
|
2024
Q4 | $109K | Hold |
|
|||||
|
2024
Q3 | $254K | Sell |
|
|||||
|
2024
Q2 | $431K | Sell |
|
|||||
|
2024
Q1 | $1.2M | Buy |
|
|||||
|
2023
Q4 | $1.51M | Buy |
|
|||||
|
2023
Q3 | $2.13M | Sell |
|
|||||
|
2023
Q2 | $4.74M | Buy |
|
|||||
|
2023
Q1 | $368K | Buy |
|
|||||
|
2022
Q4 | $1.4M | Buy |
|
|||||
|
2022
Q3 | $970K | Sell |
|
|||||
|
2022
Q2 | $1.89M | Sell |
|
|||||
|
2022
Q1 | $2.54M | Sell |
|
|||||
|
2021
Q4 | $3.68M | Buy |
|
|||||
|
2021
Q3 | $2.08M | Sell |
|
|||||
|
2021
Q2 | $13.2M | Buy |
|
|||||
|
2021
Q1 | $3.39M | Buy |
|
|||||
|
2020
Q4 | $1.11M | Buy |
|
|||||
|
2020
Q3 | $1.09M | Buy |
|
|||||
|
2020
Q2 | $544K | Buy |
|
|||||
|
2020
Q1 | $413K | Buy |
|
|||||
|
2019
Q4 | $752K | Buy |
|
|||||
|
2019
Q3 | $802K | Buy |
|
|||||
|
2019
Q2 | $768K | Buy |
|
|||||
|
2019
Q1 | $458K | Hold |
|
|||||
|
2018
Q4 | $632K | Hold |
|
|||||
|
2018
Q3 | $957K | Buy |
|
|||||
|
2018
Q2 | $783K | Buy |
|
|||||
|
2018
Q1 | $59K | Hold |
|
|||||
|
2017
Q4 | $45K | Hold |
|
|||||
|
2017
Q3 | $88K | Hold |
|
|||||
|
2017
Q2 | $88K | Buy |
|
|||||
|
2017
Q1 | $103K | Buy |
|
|||||
|
2016
Q4 | $89K | Buy |
|
|||||
|
2016
Q3 | $130K | Buy |
|
|||||
|
2016
Q2 | $77K | Hold |
|
|||||
|
2016
Q1 | $14 | Sell |
|
|||||
|
2015
Q4 | $140K | Buy |
|
|||||
|
2015
Q3 | $112K | Buy |
|
|||||
|
2015
Q2 | $131K | Buy |
|
|||||
|
2015
Q1 | $348K | Buy |
|
|||||
|
2014
Q4 | $367K | Buy |
|
|||||
|
2014
Q3 | $343K | Buy |
|
|||||
|
2014
Q2 | $313K | Buy |
|
|||||
|
2014
Q1 | $350K | Buy |
|